NSRGY News and Press, Nestle SA ADR Reg Shs Ser B From 09/08/20

Shares of the peanut allergy drugmaker Aimmune Therapeutics (NASDAQ: AIMT) jumped by a jaw-dropping 159% during August, according to data provided by S&P Global Market Intelligence . The biopharma's shares took flight last month after the announcement of a $2.6 billion merger agreement...

This article is part of a series that provides an ongoing analysis of the changes made to Gardner Russo & Gardner’s 13F stock portfolio on a quarterly basis. It is based on Russo’s regulatory 13F Form filed on 08/14/2020. Please visit our Tracking Gardner Russo & Gardn...

A recent buyout offer for Aimmune (NASDAQ: AIMT) from its deep-pocketed collaboration partner, Nestle (OTC: NSRGY) , drove the biotech stock around 172% higher overnight. As is usually the case following one of these lucrative cash deals, lots of investors have started searching the healt...

The U.S. Federal Trade Commission (FTC) has voted 3-1-1 approving a final order settling charges that AbbVie's ( ABBV +0.1% ) $63B takeover of Allergan would violate federal antitrust law. More news on: AbbVie Inc., Nestlé S.A., AstraZeneca PLC, Healthcare stocks news, Merger &...

Monday was a mixed day on Wall Street, as the Dow Jones Industrial Average (DJINDICES: ^DJI) and S&P 500 (SNPINDEX: ^GSPC) lost ground despite another record showing for the Nasdaq Composite. Yet even with the losses for the day, the Dow and S&P were up around 8% in August, strin...

Shares of Aimmune Therapeutics (NASDAQ: AIMT) jumped by an eye-popping 170% in pre-market trading Monday morning. The biotech's stock is screaming higher this morning in response to a $2.6 billion merger agreement -- on a fully diluted basis -- with Nestle 's (OTC: NSRGY) Health Science d...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . High profile stock splits Excitement is percolating around two of the market's favorite stocks as Apple (NASDAQ:AAPL) begins trading...

Nestle's ( OTCPK:NSRGY ) Health Scinece division (NHSc) has entered into a definitive agreement to acquire peanut allergy treatment maker Aimmune Therapeutics (NASDAQ: AIMT ) . More news on: Nestlé S.A., Aimmune Therapeutics, Inc., Nestlé S.A., Healthcare stocks news, Re...

This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 08/17/2020. Please visit our Tracking Dan Loeb’s Third Point Portfoli...

We made over a 40% return on our short position in Beyond Meat (BYND) in less than two months after we announced that we're shorting the stock at ~$110 per share in early February. Our DCF model back then showed that the company trades at a premium and its stock has all the chances to deprec...